|Dr. Michael S. Perry||CEO & Director||N/A||N/A||1959|
|Mr. Timothy Rooney||Chief Admin. Officer & Interim CFO||N/A||N/A||N/A|
|Mr. Andrew Quick||Chief Technology Officer||N/A||N/A||N/A|
|Ms. Erin Liberto||Chief Commercial Officer||N/A||N/A||N/A|
|Mr. Adam Kelliher||Consultant||N/A||N/A||N/A|
Avita Medical Limited operates as a regenerative medicine company in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. It offers regenerative products for the treatment of burns, chronic wounds, and aesthetics indications. The company's patented and proprietary collection and application technology provides treatment solutions derived from a patient's own skin. Its lead product, RECELL System, is used in the treatment of various skin defects, such as burns and plastic reconstructive procedures. The company also offers ReGenerCell for chronic wounds and ReNovaCell for the restoration of pigmentation. Avita Medical Limited is based in Valencia, California.
Avita Medical Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.